Vanguard Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $226M | Sell |
|
|||||
|
2025
Q2 | $176M | Buy |
|
|||||
|
2025
Q1 | $222M | Buy |
|
|||||
|
2024
Q4 | $321M | Buy |
|
|||||
|
2024
Q3 | $283M | Buy |
|
|||||
|
2024
Q2 | $376M | Buy |
|
|||||
|
2024
Q1 | $559M | Sell |
|
|||||
|
2023
Q4 | $572M | Buy |
|
|||||
|
2023
Q3 | $360M | Buy |
|
|||||
|
2023
Q2 | $856M | Sell |
|
|||||
|
2023
Q1 | $629M | Buy |
|
|||||
|
2022
Q4 | $476M | Buy |
|
|||||
|
2022
Q3 | $617M | Buy |
|
|||||
|
2022
Q2 | $395M | Buy |
|
|||||
|
2022
Q1 | $435M | Buy |
|
|||||
|
2021
Q4 | $374M | Buy |
|
|||||
|
2021
Q3 | $223M | Buy |
|
|||||
|
2021
Q2 | $401M | Buy |
|
|||||
|
2021
Q1 | $262M | Buy |
|
|||||
|
2020
Q4 | $317M | Buy |
|
|||||
|
2020
Q3 | $130M | Sell |
|
|||||
|
2020
Q2 | $143M | Buy |
|
|||||
|
2020
Q1 | $81.3M | Buy |
|
|||||
|
2019
Q4 | $73.9M | Buy |
|
|||||
|
2019
Q3 | $52M | Buy |
|
|||||
|
2019
Q2 | $52M | Buy |
|
|||||
|
2019
Q1 | $39.1M | Buy |
|
|||||
|
2018
Q4 | $19M | Buy |
|
|||||
|
2018
Q3 | $25.2M | Buy |
|
|||||
|
2018
Q2 | $29.5M | Buy |
|
|||||
|
2018
Q1 | $8.46M | Buy |
|
|||||
|
2017
Q4 | $5.95M | Buy |
|